Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02003638 · ClinicalTrials.gov registry record · NA
Assessment Of Vascular Health After Niacin Therapy (AVANT)
A NA study of Coronary Artery Disease and Peripheral Artery Disease, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT02003638: Completed NA study of Coronary Artery Disease and Peripheral Artery Disease, sponsored by University of Pennsylvania.
NCT02003638 is a NA study of Coronary Artery Disease and Peripheral Artery Disease that has completed, run by University of Pennsylvania. The registered enrollment target is 9 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02003638, a NA study of Coronary Artery Disease and Peripheral Artery Disease, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is looking to see if niacin will lessen atherosclerotic plaque inflammation and favorably affect circulating levels of endothelial progenitor cells and microparticles in people with atherosclerotic disease on chronic statin therapy.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Niacin
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-01 |
| Phase | NA |
What the finished NCT02003638 record still lists
NCT02003638 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02003638 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02003638 about?
NCT02003638 is a clinical study titled "Assessment Of Vascular Health After Niacin Therapy (AVANT)". This study is looking to see if niacin will lessen atherosclerotic plaque inflammation and favorably affect circulating levels of endothelial progenitor cells and microparticles in people with atherosclerotic disease on chronic statin therapy.
What is the current status of trial NCT02003638?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2012-03. Estimated completion is 2013-01.
What conditions does trial NCT02003638 study?
This clinical trial studies the following conditions: Coronary Artery Disease, Peripheral Artery Disease, Carotid Artery Disease.
What interventions are being tested in trial NCT02003638?
The interventions under investigation include: Placebo (DRUG), Niacin (DRUG).
Who is sponsoring clinical trial NCT02003638?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02003638 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02003638's enrollment target sits among peer trials
9 219th of 219 higher than 1 of 219 other Coronary Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
-
Intravascular Lithotripsy With or Without Rotational Atherectomy for Coronary Calcified Nodule Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia